Skip to content

Author

S. Haryono

We have 2 of 47 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Determinants of survival in triple-negative breast cancer: A clinicopathological study from an Indonesian Cancer Center

A BSTRACT Triple-negative breast cancer (TNBC) outcomes in Southeast Asian and resource-limited settings remain underreported. This study evaluated factors associated with 3-year overall survival (OS), event-free survival (EFS) in stage I–IIIC disease, and progression-free survival (PFS) in stage IV disease....

S. Haryono, Yuniar Harris Prayitno, N. Sutandyo · 0 citations
Review Open access Sep 2026

CDK4/6 Inhibitors in the Management of Hormone Receptor-Positive (HR+)/Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Advanced Breast Cancer in Indonesia: Challenges, Opportunities, and Recommendations.

A review underscores the critical role of CDK4/6 inhibitors in the treatment of HR+/HER2- ABC, with a particular focus on Indonesian patients, and supports consideration of these agents for inclusion in national clinical guidelines to enhance patient outcomes.

S. S. Panigoro, S. Haryono, P. Prihantono et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.